Skip to main content

Advertisement

Log in

Prion disease

Diagnostic value of cerebrospinal fluid markers

  • News & Views
  • Published:

From Nature Reviews Neurology

View current issue Sign up to alerts

Differential diagnosis of Creutzfeldt–Jakob disease (CJD) versus other—sometimes treatable—neurological disorders is challenging, owing in part to uncertainty about the utility of recommended diagnostic tools. Two recent studies have addressed the reliability of cerebrospinal fluid biomarkers in identification of patients with sporadic CJD among clinically suspected cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hsich, G., Kenney, K., Gibbs, C. J., Lee, K. H. & Harrington, M. G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 335, 924–930 (1996).

    Article  CAS  Google Scholar 

  2. Zerr, I. et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease. Neurology 55, 811–815 (2000).

    Article  CAS  Google Scholar 

  3. Zerr, I. et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Brain 132, 2659–2668 (2009).

    Article  CAS  PubMed  Google Scholar 

  4. Geschwind, M. D. et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt–Jakob disease. Arch. Neurol. 60, 813–816 (2003).

    Article  PubMed  Google Scholar 

  5. Muayqil, T., Gronseth, G. & Camicioli, R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt–Jakob disease: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 79, 1499–1506 (2012).

    Article  CAS  PubMed  Google Scholar 

  6. Stoeck, K. et al. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain 135, 3051–3061 (2012).

    Article  PubMed  Google Scholar 

  7. Chitravas, N. et al. Treatable neurological disorders misdiagnosed as Creutzfeldt–Jakob disease. Ann. Neurol. 70, 437–444 (2011).

    Article  PubMed  Google Scholar 

  8. Parchi, P., Strammiello, R., Giese, A. & Kretzschmar, H. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. Acta Neuropathol. 121, 91–112 (2011).

    Article  CAS  Google Scholar 

  9. Zou, W. Q. et al. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann. Neurol. 68, 162–172 (2010).

    Article  CAS  PubMed  Google Scholar 

  10. Atarashi, R. et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat. Med. 17, 175–178 (2011).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Piero Parchi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parchi, P., Capellari, S. Diagnostic value of cerebrospinal fluid markers. Nat Rev Neurol 9, 10–11 (2013). https://doi.org/10.1038/nrneurol.2012.253

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2012.253

  • Springer Nature Limited

This article is cited by

Navigation